Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 293,764 | 196,754 | 57,461 | 25,777 | N/A |
| TOTAL | $301,037 | $198,182 | $58,252 | $26,383 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 13,453 | 838 | 514 | 387 | N/A |
| Investments And Advances | 1,069 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 75 | 179 | 20 | 0 |
| TOTAL | $14,522 | $913 | $693 | $407 | $N/A |
| Total Assets | $315,559 | $199,095 | $58,945 | $26,790 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,308 | 4,395 | 1,413 | 1,600 | 0 |
| Accrued Expenses | 13,709 | 9,233 | 2,957 | 1,263 | N/A |
| TOTAL | $22,743 | $13,815 | $4,557 | $3,050 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,107 | 1,294 | 1,481 | 1,679 | N/A |
| Other Non-Current Liabilities | 11,728 | 13 | 0 | 0 | 0 |
| TOTAL | $12,835 | $1,307 | $1,481 | $1,679 | $N/A |
| Total Liabilities | $35,578 | $15,122 | $6,038 | $4,729 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,189 | N/A | N/A | N/A | N/A |
| Common Shares | 377 | 326 | N/A | N/A | N/A |
| Retained earnings | -295,723 | -195,869 | -145,585 | -119,645 | N/A |
| TOTAL | $279,981 | $183,973 | $52,907 | $22,061 | $N/A |
| Total Liabilities And Equity | $315,559 | $199,095 | $58,945 | $26,790 | $0 |